Polydeoxyribonucleotide for Elbow Lateral Epicondylitis
NCT ID: NCT06753630
Last Updated: 2024-12-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2014-11-20
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does the addition of PDRN improve pain reduction as measured by the Visual Analog Scale (VAS)? Does the addition of PDRN enhance functional outcomes such as the Mayo Elbow Performance Score (MEPS) and Hand Grip Strength Index (HGSI)?
Researchers will compare two groups to see if PDRN provides additional benefits:
Group 1: EMSE + ESWT + saline injection Group 2: EMSE + ESWT + PDRN injection
Participants will:
Perform extensor muscle strengthening exercises Receive extracorporeal shockwave therapy Receive either a saline injection or a PDRN injection at the first outpatient department visit Attend follow-up visits at 6 and 12 weeks for assessments
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (G1): EMSE + ESWT + Saline Injection
Participants in this group will perform extensor muscle strengthening exercises and receive extracorporeal shockwave therapy. Additionally, they will receive a 3mL saline injection at the first outpatient department visit.
Extensor Muscle Strengthening Exercise
A series of exercises aimed at strengthening the extensor muscles of the forearm to alleviate symptoms of lateral epicondylitis.
Extracorporeal Shockwave Therapy
A non-invasive procedure that uses shockwaves to promote healing and reduce pain in the affected area.
Saline injection (Octreotide LAR placebo)
A 3mL injection of saline solution used as a placebo in the study.
Group 2 (G2): EMSE + ESWT + PDRN Injection
Participants in this group will perform extensor muscle strengthening exercises and receive extracorporeal shockwave therapy. Additionally, they will receive a 3mL injection of polydeoxyribonucleotide (PDRN) at the first outpatient department visit.
Extensor Muscle Strengthening Exercise
A series of exercises aimed at strengthening the extensor muscles of the forearm to alleviate symptoms of lateral epicondylitis.
Extracorporeal Shockwave Therapy
A non-invasive procedure that uses shockwaves to promote healing and reduce pain in the affected area.
Polydeoxyribonucleotide Injection
A 3mL injection of polydeoxyribonucleotide (5.625mg/3mL) used to enhance the healing process and improve outcomes in lateral epicondylitis treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extensor Muscle Strengthening Exercise
A series of exercises aimed at strengthening the extensor muscles of the forearm to alleviate symptoms of lateral epicondylitis.
Extracorporeal Shockwave Therapy
A non-invasive procedure that uses shockwaves to promote healing and reduce pain in the affected area.
Saline injection (Octreotide LAR placebo)
A 3mL injection of saline solution used as a placebo in the study.
Polydeoxyribonucleotide Injection
A 3mL injection of polydeoxyribonucleotide (5.625mg/3mL) used to enhance the healing process and improve outcomes in lateral epicondylitis treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chuncheon Sacred Heart Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung-Taek Hwang
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chuncheon Sacred Heart Hospital
Chuncheon, Gangwon-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-100
Identifier Type: -
Identifier Source: org_study_id